Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia

Prophylactic low molecular weight heparin (pLMWH) is currently recommended in COVID-19 to reduce the risk of coagulopathy. The aim of this study was to evaluate whether the antinflammatory effects of pLMWH could translate in lower rate of clinical progression in patients with COVID-19 pneumonia. Pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vergori, Alessandra, Lorenzini, Patrizia, Cozzi-Lepri, Alessandro, Donno, Davide Roberto, Gualano, Gina, Nicastri, Emanuele, Iacomi, Fabio, Marchioni, Luisa, Campioni, Paolo, Schininà, Vincenzo, Cicalini, Stefania, Agrati, Chiara, Capobianchi, Maria Rosaria, Girardi, Enrico, Ippolito, Giuseppe, Vaia, Francesco, Petrosillo, Nicola, Antinori, Andrea, Taglietti, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167179/
https://www.ncbi.nlm.nih.gov/pubmed/34059708
http://dx.doi.org/10.1038/s41598-021-90713-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167179/
https://www.ncbi.nlm.nih.gov/pubmed/34059708
http://dx.doi.org/10.1038/s41598-021-90713-6

Ejemplares similares